#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Non-small cell lung cancer metastatic Asthma Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic cutaneous lupus erythematosus Progressive familial intrahepatic cholestasis Autoimmune demyelinating disease Cystic fibrosis respiratory infection suppression Hepatoblastoma Enteritis Epstein-Barr virus associated lymphoproliferative disorder Hodgkin's disease recurrent Von Hippel-Lindau disease Fungal infection Synovial sarcoma metastatic Aplastic anaemia Mucopolysaccharidosis III Short stature homeobox gene mutation Hereditary angioedema with C1 esterase inhibitor deficiency More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome – Diagnostics Immunodeficiency congenital – Diagnostics Combined immunodeficiency Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Life with Disease Pleomorphic leiomyosarcoma – Basic Information X-linked lymphoproliferative syndrome – Trials in Disease Testicular leiomyosarcoma – Basic Information Haemophagocytic lymphohistiocytosis – Trials in Disease Leukoencephalopathy – Treatment Fabry’s disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sultiame Nedosiran Avibactam Zimberelimab BRENSOCATIB Spartalizumab IHMA-2121771-2 Vesleteplirsen Regtivex Cannabis Sativa Flower Oseltamivir Anhydrous Azithromycin ALKYLATING AGENTS Repagermanium Ondansetron Soya Oil Lansoprazole Estriol ZINC Rmc-035 More therapies…

    Learn about Your Condition

    HER2 positive gastric cancer Lung transplant Cortical dysplasia Bronchiectasis Chronic hepatitis C Pulmonary congestion Autoimmune hepatitis Hepatorenal syndrome Primary amyloidosis Acute cardiac event Hepatobiliary disease Ocular lymphoma Anaemia Head and neck cancer stage IV Morning sickness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. 3 F s.r.o.

3 F s.r.o.

Toryska 1, Zapad, Kosice, 040 11, Slovakia

Want to learn more about this study or check if you can participate? Contact us.

  • Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Belgium Bulgaria Czechia Denmark Germany Hungary +6

  • Study Comparing EYP-1901 and Aflibercept for Patients with Wet Age-Related Macular Degeneration

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Neovascular age-related macular degeneration
    Investigated Drugs:
    • Aflibercept
    • VOROLANIB
    Czechia Germany Hungary Poland Slovakia

  • Study of Atropine Sulfate eye drops (0.

    Not recruiting

    3 1
    Investigated Diseases:
    • Myopia
    Investigated Drugs:
    • Atropine Sulfate
    Hungary Ireland Poland Slovakia Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!